CIK: 1425738 - Address: One Letterman Drive, Building D, Suite D3-300, San Francisco, CA 94129
11 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

7/3/24 20:00
7/1/24
ADCTAdc Therapeutics SaV8HealthDrugPharmaceutical PreparationsRedmile Group, LLCCATP2,2482.810800328,664M
3/5/24 21:30
3/1/24
ABSIAbsci CorpHealthBiolabCommercial Physical & BiologiRedmile Group, LLCCADP1,0004.50022238,253I
12/28/23 21:30
12/26/23
FATEFate Therapeutics IncHealthBioPrdBiological Products, (No DiagRedmile Group, LLCCADTP1663.72045013,180I
11/22/23 16:15
11/20/23
AUGXAugmedix, Inc.DEBizSvBizSvBusiness ServicesRedmile Group, LLCCADTP.d6,0004.0001,500625,850M
7/3/23 21:45
6/29/23
IGMSIgm Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsRedmile Group, LLCCADS-7589.420-80-15,949I
7/3/23 21:45
6/29/23
IGMSIgm Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsRedmile Group, LLCCADP7589.4208015,949I
4/21/23 21:55
4/20/23
FATEFate Therapeutics IncHealthBioPrdBiological Products, (No DiagRedmile Group, LLCCADTP.m1,7066.170277213,136I
4/21/23 21:53
10/28/21
AUGXAugmedix, Inc.DEBizSvBizSvBusiness ServicesRedmile Group, LLCCADTP.a6,5004.0001,625356,218D
4/17/23 21:30
4/14/23
FATEFate Therapeutics IncHealthBioPrdBiological Products, (No DiagRedmile Group, LLCCADTS.d-1,7665.840-302-212,859I
4/17/23 21:30
4/14/23
FATEFate Therapeutics IncHealthBioPrdBiological Products, (No DiagRedmile Group, LLCCADTP.d1546.00026012,859I
10/18/22 06:07
10/13/22
ZYMEZymeworks Inc.DEHealthDrugPharmaceutical PreparationsRedmile Group, LLCCATP.a1535.0303016,076I

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact